Screener
Castle Biosciences CSTL Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's invested capital?
- Castle Biosciences (CSTL) reported invested capital of $434.38M in Q1 2026.
- How has Castle Biosciences's invested capital changed year-over-year?
- Castle Biosciences's invested capital increased by 15.4% year-over-year, from $376.46M to $434.38M.
- What is the long-term trend for Castle Biosciences's invested capital?
- Over 4 years (2021 to 2025), Castle Biosciences's invested capital has grown at a 44.2% compound annual growth rate (CAGR), from $90.42M to $391.16M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Castle Biosciences's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude